Evidence map›Paper›PMID 39595926›Full record

ArticleInternational journal of molecular sciences2024

Pablo Shimaoka Chagas, Cristiana Bernadelli Garcia, Lucas Oliveira Sousa, Gabriel da Silva, Graziella Ribeiro de Sousa, Rodolfo Cabral Marcelino, Leandro Luongo de Matos, Luiz Paulo Kowalski, Évila Salles, Lei Wang and 2 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Pablo Shimaoka ChagasDepartment of Clinical Analyses, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Av. do Café s/n, Ribeirão Preto 14040-903, SP, Brazil.ORCID 0000-0002-0652-728X
Cristiana Bernadelli GarciaDepartment of Clinical Analyses, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Av. do Café s/n, Ribeirão Preto 14040-903, SP, Brazil.
Lucas Oliveira SousaDepartment of Clinical Analyses, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Av. do Café s/n, Ribeirão Preto 14040-903, SP, Brazil.ORCID 0000-0002-8234-2746
Gabriel da SilvaDepartment of Clinical Analyses, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Av. do Café s/n, Ribeirão Preto 14040-903, SP, Brazil.
Graziella Ribeiro de SousaDepartment of Clinical Analyses, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Av. do Café s/n, Ribeirão Preto 14040-903, SP, Brazil.
Rodolfo Cabral MarcelinoLaboratory of Molecular Modeling and Computer Simulation/MolMod-CS, Institute of Chemistry, Federal University of Alfenas, Alfenas 37130-001, MG, Brazil.ORCID 0000-0002-5320-3907
Leandro Luongo de MatosHead and Neck Surgery Department, Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas, University of São Paulo Medical School (ICESP HCFMUSP), São Paulo 01246-000, SP, Brazil.ORCID 0000-0002-5068-8208
Luiz Paulo KowalskiHead and Neck Surgery Department, University of São Paulo Medical School, São Paulo 05403-000, SP, Brazil.ORCID 0000-0002-0481-156X
Évila SallesDepartment of Oral Biology and Diagnostic Services, Dental College of Georgia, Augusta University, Augusta, GA 30912, USA.ORCID 0000-0001-6956-7409
Lei WangDepartment of Oral Biology and Diagnostic Services, Dental College of Georgia, Augusta University, Augusta, GA 30912, USA.
Babak BabanDepartment of Oral Biology and Diagnostic Services, Dental College of Georgia, Augusta University, Augusta, GA 30912, USA.ORCID 0000-0002-3144-2288
Andréia Machado LeopoldinoDepartment of Clinical Analyses, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Av. do Café s/n, Ribeirão Preto 14040-903, SP, Brazil.ORCID 0000-0002-8313-4754

Funding

Fundação de Amparo a Pesquisa do Estado de São Paulo 2016/19103-2Fundação de Amparo a Pesquisa do Estado de São Paulo 2022/07821-9Fundação de Amparo à Pesquisa do Estado de São Paulo 2021/03732-9
6 · The paper itself

Abstract

Emerging evidence suggests that aberrant expression levels of Sigma1 (

Indexed as

B7-H1 AntigenCisplatinGene Expression Regulation, NeoplasticGene Knockdown TechniquesMouth NeoplasmsReceptors, sigmaSigma-1 ReceptorAntineoplastic AgentsApoptosisCell Line, TumorDrug Resistance, NeoplasmFemaleHumansMaleMiddle AgedAntineoplastic AgentsB7-H1 AntigenCD274 protein, humanCisplatinReceptors, sigmaSigma-1 Receptorimmunotherapyoral cancerPD-L1SIGMAR1

Identifiers

PMID39595926
PMCPMC11594079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.